N-methyl-1-(tetrahydro-2H-pyran-2-yl)methanamine, 95.0%, 1g

2-Amino-5-methoxy-1-methylbenzimidazole, 95.0%, 1g

Ethyl 5-oxo-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate, 95.0%, 1g

(R)-6-fluoro-3-(3-fluorophenyl)-2-(1-hydroxyethyl)-4H-chromen-4-one, 97%, 1g

Single-channel microliter pipette Pipetman® L, 20 to 200 µl, P200L, 1 piece

2-Amino-2-(4-fluoro-phenyl)-propionic acid, 95%, 100mg

4-((2,4-dinitrophenyl)amino)butanoic acid, 95.0%, 1g

Rebaudioside A>98.0%(HPLC)5g

N-(5-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PYRIDIN-2-YL)-2,5-DIOXO-1-PHENYL-1,2,5,6,7,8-HEXAHYDROQUINOLINE-3-CARBOXAMIDE, 95%, 100mg

Octahydro-1H-4,7-methanoinden-5-ol, 95.0%, 5g

1-(2-Methoxyethyl)-4-nitro-1h-pyrazole, 97%, 250mg

(2E)-3-(2H-1,3-benzodioxol-5-yl)-1-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

N,N-Dimethyl-2-phenylacetamide, 99.0%, 250mg